MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$578,618,000
Unrealized gain (loss) on
marketable securities
$2,886,000
Foreign currency
translation adjustment
$95,000
Net loss
-$581,599,000
Other income, net
$86,606,000
Net loss before
income taxes
-$577,965,000
Provision for income taxes
$3,634,000
Total other income,
net
$86,606,000
Grant
$3,510,000
Loss from operations
-$664,571,000
Total revenue
$3,510,000
Total operating
expenses
$668,081,000
Research and development
$284,806,000
Collaboration expense, net
$213,480,000
Acquired in-process
research and development
$96,253,000
General and
administrative
$73,542,000
Back
Back
Income Statement
source: myfinsight.com
CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG (CRSP)